Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth
- Autores
- Macías Saint Gerons, Diego; Rodovalho, Sheila; Barros Dias, Ádila Liliane; Lacerda Ulysses de Carvalho, André; Beratarrechea, Andrea Gabriela; Monteiro, Wuelton Marcelo; Barata Machado, Myrna; Fernandes da Costa, Cristiano; Yoshito Wada, Marcelo; Maximiano Faria de Almeida, Márcia Helena; Silva de Matos Fonseca, Rayanne; Mota Cordeiro, Jady Shayenne; Rodrigues Antolini, Alinne Paula; Nepomuceno, João Altecir; Fleck, Karen; Simioni Gasparotto, Fernanda; Lacerda, Marcus; Rojas Cortés, Robin; Pal, Shanthi Narayan; Porrás, Analía I.; Ade, María de la Paz; Castro, José Luis
- Año de publicación
- 2022
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background: Public health initiatives for improving adherence to primaquine based regimens and enhancing effective pharmacovigilance are needed to support the efforts for malaria elimination in real world conditions. Methods: A multicomponent patient-oriented strategy using a Smart Safety Surveillance (3S) approach including: (1) educational materials for treatment counselling and identification of warning symptoms of haemolytic anaemia; (2) an mHealth component using Short Message Service (SMS) treatment reminders and (3) development and implementation of follow-up phone surveys three days after treatment completion, using a web-based platform linked to the local information system of malaria. Adherence was measured using the Morisky Medication Adherence Scale. Self-reported events were registered using a structured questionnaire and communicated to the Brazilian Health Regulatory Agency. Results: Educational materials were disseminated to 5594 patients, of whom 1512 voluntarily entered the mHealth component through the local information system; 7323 SMS were sent, and 1062 participants completed a follow-up survey after treatment. The mean age of patients was 37.36 years (SD 13.65), 61.24% were male, 98.54% were infected with. Plasmodium vivax and 95.90% received a short regimen of chloroquine plus primaquine (CQ + PQ 7 days), as per malaria case management guidelines in Brazil. From the 1062 surveyed participants 93.31% were considered adherent to the treatment. Most of the patients (95.20%) reported at least one adverse event. Headache, lack of appetite and nausea/vomiting were the most frequently reported adverse events by 77.31%, 70.90% and 56.78% of the patients respectively. A quarter of the patients reported anxiety or depression symptoms; 57 (5.37%) patients reported 5 to 6 warning symptoms of haemolytic anaemia including jaundice and dark urine in 44 (4.14%). Overall, three patients presenting symptoms of haemolytic anaemia attended a hospital and were diagnosed with G6PD deficiency, and one had haemolysis. All of them recovered. Conclusions: Under real world conditions, a multicomponent patient-oriented strategy using information and communication technologies allowed health care providers to reinforce treatment adherence and enhance safety surveillance of adverse events associated with regimens using primaquine. Active monitoring through phone surveys also reduced under-reporting of ADRs. This approach is low-cost, scalable and able to support prioritized activities of the national malaria programme.
Fil: Macías Saint Gerons, Diego. Universidad de Valencia; España
Fil: Rodovalho, Sheila. Universidad Federal del Amazonas.; Brasil
Fil: Barros Dias, Ádila Liliane. Universidad Federal del Amazonas.; Brasil
Fil: Lacerda Ulysses de Carvalho, André. Pan American Health Organization; Brasil
Fil: Beratarrechea, Andrea Gabriela. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Monteiro, Wuelton Marcelo. Universidad Federal del Amazonas.; Brasil
Fil: Barata Machado, Myrna. State of Amazonas Health Surveillance Foundation; Brasil
Fil: Fernandes da Costa, Cristiano. State of Amazonas Health Surveillance Foundation; Brasil
Fil: Yoshito Wada, Marcelo. No especifíca;
Fil: Maximiano Faria de Almeida, Márcia Helena. No especifíca;
Fil: Silva de Matos Fonseca, Rayanne. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; Brasil
Fil: Mota Cordeiro, Jady Shayenne. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; Brasil
Fil: Rodrigues Antolini, Alinne Paula. No especifíca;
Fil: Nepomuceno, João Altecir. No especifíca;
Fil: Fleck, Karen. Brazilian Health Regulatory Agency; Brasil
Fil: Simioni Gasparotto, Fernanda. Brazilian Health Regulatory Agency; Brasil
Fil: Lacerda, Marcus. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; Brasil
Fil: Rojas Cortés, Robin. Pan American Health Organization; Estados Unidos
Fil: Pal, Shanthi Narayan. No especifíca;
Fil: Porrás, Analía I.. Pan American Health Organization; Estados Unidos
Fil: Ade, María de la Paz. Pan American Health Organization; Estados Unidos
Fil: Castro, José Luis. Pan American Health Organization; Estados Unidos - Materia
-
ADHERENCE
MHEALTH
PHARMACOVIGILANCE
PRIMAQUINE
SMS - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/187848
Ver los metadatos del registro completo
id |
CONICETDig_acbb1d24402382d5cc386eb2203bce55 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/187848 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealthMacías Saint Gerons, DiegoRodovalho, SheilaBarros Dias, Ádila LilianeLacerda Ulysses de Carvalho, AndréBeratarrechea, Andrea GabrielaMonteiro, Wuelton MarceloBarata Machado, MyrnaFernandes da Costa, CristianoYoshito Wada, MarceloMaximiano Faria de Almeida, Márcia HelenaSilva de Matos Fonseca, RayanneMota Cordeiro, Jady ShayenneRodrigues Antolini, Alinne PaulaNepomuceno, João AltecirFleck, KarenSimioni Gasparotto, FernandaLacerda, MarcusRojas Cortés, RobinPal, Shanthi NarayanPorrás, Analía I.Ade, María de la PazCastro, José LuisADHERENCEMHEALTHPHARMACOVIGILANCEPRIMAQUINESMShttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Background: Public health initiatives for improving adherence to primaquine based regimens and enhancing effective pharmacovigilance are needed to support the efforts for malaria elimination in real world conditions. Methods: A multicomponent patient-oriented strategy using a Smart Safety Surveillance (3S) approach including: (1) educational materials for treatment counselling and identification of warning symptoms of haemolytic anaemia; (2) an mHealth component using Short Message Service (SMS) treatment reminders and (3) development and implementation of follow-up phone surveys three days after treatment completion, using a web-based platform linked to the local information system of malaria. Adherence was measured using the Morisky Medication Adherence Scale. Self-reported events were registered using a structured questionnaire and communicated to the Brazilian Health Regulatory Agency. Results: Educational materials were disseminated to 5594 patients, of whom 1512 voluntarily entered the mHealth component through the local information system; 7323 SMS were sent, and 1062 participants completed a follow-up survey after treatment. The mean age of patients was 37.36 years (SD 13.65), 61.24% were male, 98.54% were infected with. Plasmodium vivax and 95.90% received a short regimen of chloroquine plus primaquine (CQ + PQ 7 days), as per malaria case management guidelines in Brazil. From the 1062 surveyed participants 93.31% were considered adherent to the treatment. Most of the patients (95.20%) reported at least one adverse event. Headache, lack of appetite and nausea/vomiting were the most frequently reported adverse events by 77.31%, 70.90% and 56.78% of the patients respectively. A quarter of the patients reported anxiety or depression symptoms; 57 (5.37%) patients reported 5 to 6 warning symptoms of haemolytic anaemia including jaundice and dark urine in 44 (4.14%). Overall, three patients presenting symptoms of haemolytic anaemia attended a hospital and were diagnosed with G6PD deficiency, and one had haemolysis. All of them recovered. Conclusions: Under real world conditions, a multicomponent patient-oriented strategy using information and communication technologies allowed health care providers to reinforce treatment adherence and enhance safety surveillance of adverse events associated with regimens using primaquine. Active monitoring through phone surveys also reduced under-reporting of ADRs. This approach is low-cost, scalable and able to support prioritized activities of the national malaria programme.Fil: Macías Saint Gerons, Diego. Universidad de Valencia; EspañaFil: Rodovalho, Sheila. Universidad Federal del Amazonas.; BrasilFil: Barros Dias, Ádila Liliane. Universidad Federal del Amazonas.; BrasilFil: Lacerda Ulysses de Carvalho, André. Pan American Health Organization; BrasilFil: Beratarrechea, Andrea Gabriela. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Monteiro, Wuelton Marcelo. Universidad Federal del Amazonas.; BrasilFil: Barata Machado, Myrna. State of Amazonas Health Surveillance Foundation; BrasilFil: Fernandes da Costa, Cristiano. State of Amazonas Health Surveillance Foundation; BrasilFil: Yoshito Wada, Marcelo. No especifíca;Fil: Maximiano Faria de Almeida, Márcia Helena. No especifíca;Fil: Silva de Matos Fonseca, Rayanne. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; BrasilFil: Mota Cordeiro, Jady Shayenne. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; BrasilFil: Rodrigues Antolini, Alinne Paula. No especifíca;Fil: Nepomuceno, João Altecir. No especifíca;Fil: Fleck, Karen. Brazilian Health Regulatory Agency; BrasilFil: Simioni Gasparotto, Fernanda. Brazilian Health Regulatory Agency; BrasilFil: Lacerda, Marcus. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; BrasilFil: Rojas Cortés, Robin. Pan American Health Organization; Estados UnidosFil: Pal, Shanthi Narayan. No especifíca;Fil: Porrás, Analía I.. Pan American Health Organization; Estados UnidosFil: Ade, María de la Paz. Pan American Health Organization; Estados UnidosFil: Castro, José Luis. Pan American Health Organization; Estados UnidosBioMed Central2022-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/187848Macías Saint Gerons, Diego; Rodovalho, Sheila; Barros Dias, Ádila Liliane; Lacerda Ulysses de Carvalho, André; Beratarrechea, Andrea Gabriela; et al.; Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth; BioMed Central; Malaria Journal; 21; 1; 12-2022; 1-111475-2875CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1186/s12936-022-04047-3info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:05:55Zoai:ri.conicet.gov.ar:11336/187848instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:05:55.563CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth |
title |
Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth |
spellingShingle |
Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth Macías Saint Gerons, Diego ADHERENCE MHEALTH PHARMACOVIGILANCE PRIMAQUINE SMS |
title_short |
Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth |
title_full |
Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth |
title_fullStr |
Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth |
title_full_unstemmed |
Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth |
title_sort |
Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth |
dc.creator.none.fl_str_mv |
Macías Saint Gerons, Diego Rodovalho, Sheila Barros Dias, Ádila Liliane Lacerda Ulysses de Carvalho, André Beratarrechea, Andrea Gabriela Monteiro, Wuelton Marcelo Barata Machado, Myrna Fernandes da Costa, Cristiano Yoshito Wada, Marcelo Maximiano Faria de Almeida, Márcia Helena Silva de Matos Fonseca, Rayanne Mota Cordeiro, Jady Shayenne Rodrigues Antolini, Alinne Paula Nepomuceno, João Altecir Fleck, Karen Simioni Gasparotto, Fernanda Lacerda, Marcus Rojas Cortés, Robin Pal, Shanthi Narayan Porrás, Analía I. Ade, María de la Paz Castro, José Luis |
author |
Macías Saint Gerons, Diego |
author_facet |
Macías Saint Gerons, Diego Rodovalho, Sheila Barros Dias, Ádila Liliane Lacerda Ulysses de Carvalho, André Beratarrechea, Andrea Gabriela Monteiro, Wuelton Marcelo Barata Machado, Myrna Fernandes da Costa, Cristiano Yoshito Wada, Marcelo Maximiano Faria de Almeida, Márcia Helena Silva de Matos Fonseca, Rayanne Mota Cordeiro, Jady Shayenne Rodrigues Antolini, Alinne Paula Nepomuceno, João Altecir Fleck, Karen Simioni Gasparotto, Fernanda Lacerda, Marcus Rojas Cortés, Robin Pal, Shanthi Narayan Porrás, Analía I. Ade, María de la Paz Castro, José Luis |
author_role |
author |
author2 |
Rodovalho, Sheila Barros Dias, Ádila Liliane Lacerda Ulysses de Carvalho, André Beratarrechea, Andrea Gabriela Monteiro, Wuelton Marcelo Barata Machado, Myrna Fernandes da Costa, Cristiano Yoshito Wada, Marcelo Maximiano Faria de Almeida, Márcia Helena Silva de Matos Fonseca, Rayanne Mota Cordeiro, Jady Shayenne Rodrigues Antolini, Alinne Paula Nepomuceno, João Altecir Fleck, Karen Simioni Gasparotto, Fernanda Lacerda, Marcus Rojas Cortés, Robin Pal, Shanthi Narayan Porrás, Analía I. Ade, María de la Paz Castro, José Luis |
author2_role |
author author author author author author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
ADHERENCE MHEALTH PHARMACOVIGILANCE PRIMAQUINE SMS |
topic |
ADHERENCE MHEALTH PHARMACOVIGILANCE PRIMAQUINE SMS |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Background: Public health initiatives for improving adherence to primaquine based regimens and enhancing effective pharmacovigilance are needed to support the efforts for malaria elimination in real world conditions. Methods: A multicomponent patient-oriented strategy using a Smart Safety Surveillance (3S) approach including: (1) educational materials for treatment counselling and identification of warning symptoms of haemolytic anaemia; (2) an mHealth component using Short Message Service (SMS) treatment reminders and (3) development and implementation of follow-up phone surveys three days after treatment completion, using a web-based platform linked to the local information system of malaria. Adherence was measured using the Morisky Medication Adherence Scale. Self-reported events were registered using a structured questionnaire and communicated to the Brazilian Health Regulatory Agency. Results: Educational materials were disseminated to 5594 patients, of whom 1512 voluntarily entered the mHealth component through the local information system; 7323 SMS were sent, and 1062 participants completed a follow-up survey after treatment. The mean age of patients was 37.36 years (SD 13.65), 61.24% were male, 98.54% were infected with. Plasmodium vivax and 95.90% received a short regimen of chloroquine plus primaquine (CQ + PQ 7 days), as per malaria case management guidelines in Brazil. From the 1062 surveyed participants 93.31% were considered adherent to the treatment. Most of the patients (95.20%) reported at least one adverse event. Headache, lack of appetite and nausea/vomiting were the most frequently reported adverse events by 77.31%, 70.90% and 56.78% of the patients respectively. A quarter of the patients reported anxiety or depression symptoms; 57 (5.37%) patients reported 5 to 6 warning symptoms of haemolytic anaemia including jaundice and dark urine in 44 (4.14%). Overall, three patients presenting symptoms of haemolytic anaemia attended a hospital and were diagnosed with G6PD deficiency, and one had haemolysis. All of them recovered. Conclusions: Under real world conditions, a multicomponent patient-oriented strategy using information and communication technologies allowed health care providers to reinforce treatment adherence and enhance safety surveillance of adverse events associated with regimens using primaquine. Active monitoring through phone surveys also reduced under-reporting of ADRs. This approach is low-cost, scalable and able to support prioritized activities of the national malaria programme. Fil: Macías Saint Gerons, Diego. Universidad de Valencia; España Fil: Rodovalho, Sheila. Universidad Federal del Amazonas.; Brasil Fil: Barros Dias, Ádila Liliane. Universidad Federal del Amazonas.; Brasil Fil: Lacerda Ulysses de Carvalho, André. Pan American Health Organization; Brasil Fil: Beratarrechea, Andrea Gabriela. Instituto de Efectividad Clínica y Sanitaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Monteiro, Wuelton Marcelo. Universidad Federal del Amazonas.; Brasil Fil: Barata Machado, Myrna. State of Amazonas Health Surveillance Foundation; Brasil Fil: Fernandes da Costa, Cristiano. State of Amazonas Health Surveillance Foundation; Brasil Fil: Yoshito Wada, Marcelo. No especifíca; Fil: Maximiano Faria de Almeida, Márcia Helena. No especifíca; Fil: Silva de Matos Fonseca, Rayanne. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; Brasil Fil: Mota Cordeiro, Jady Shayenne. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; Brasil Fil: Rodrigues Antolini, Alinne Paula. No especifíca; Fil: Nepomuceno, João Altecir. No especifíca; Fil: Fleck, Karen. Brazilian Health Regulatory Agency; Brasil Fil: Simioni Gasparotto, Fernanda. Brazilian Health Regulatory Agency; Brasil Fil: Lacerda, Marcus. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado; Brasil Fil: Rojas Cortés, Robin. Pan American Health Organization; Estados Unidos Fil: Pal, Shanthi Narayan. No especifíca; Fil: Porrás, Analía I.. Pan American Health Organization; Estados Unidos Fil: Ade, María de la Paz. Pan American Health Organization; Estados Unidos Fil: Castro, José Luis. Pan American Health Organization; Estados Unidos |
description |
Background: Public health initiatives for improving adherence to primaquine based regimens and enhancing effective pharmacovigilance are needed to support the efforts for malaria elimination in real world conditions. Methods: A multicomponent patient-oriented strategy using a Smart Safety Surveillance (3S) approach including: (1) educational materials for treatment counselling and identification of warning symptoms of haemolytic anaemia; (2) an mHealth component using Short Message Service (SMS) treatment reminders and (3) development and implementation of follow-up phone surveys three days after treatment completion, using a web-based platform linked to the local information system of malaria. Adherence was measured using the Morisky Medication Adherence Scale. Self-reported events were registered using a structured questionnaire and communicated to the Brazilian Health Regulatory Agency. Results: Educational materials were disseminated to 5594 patients, of whom 1512 voluntarily entered the mHealth component through the local information system; 7323 SMS were sent, and 1062 participants completed a follow-up survey after treatment. The mean age of patients was 37.36 years (SD 13.65), 61.24% were male, 98.54% were infected with. Plasmodium vivax and 95.90% received a short regimen of chloroquine plus primaquine (CQ + PQ 7 days), as per malaria case management guidelines in Brazil. From the 1062 surveyed participants 93.31% were considered adherent to the treatment. Most of the patients (95.20%) reported at least one adverse event. Headache, lack of appetite and nausea/vomiting were the most frequently reported adverse events by 77.31%, 70.90% and 56.78% of the patients respectively. A quarter of the patients reported anxiety or depression symptoms; 57 (5.37%) patients reported 5 to 6 warning symptoms of haemolytic anaemia including jaundice and dark urine in 44 (4.14%). Overall, three patients presenting symptoms of haemolytic anaemia attended a hospital and were diagnosed with G6PD deficiency, and one had haemolysis. All of them recovered. Conclusions: Under real world conditions, a multicomponent patient-oriented strategy using information and communication technologies allowed health care providers to reinforce treatment adherence and enhance safety surveillance of adverse events associated with regimens using primaquine. Active monitoring through phone surveys also reduced under-reporting of ADRs. This approach is low-cost, scalable and able to support prioritized activities of the national malaria programme. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-12 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/187848 Macías Saint Gerons, Diego; Rodovalho, Sheila; Barros Dias, Ádila Liliane; Lacerda Ulysses de Carvalho, André; Beratarrechea, Andrea Gabriela; et al.; Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth; BioMed Central; Malaria Journal; 21; 1; 12-2022; 1-11 1475-2875 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/187848 |
identifier_str_mv |
Macías Saint Gerons, Diego; Rodovalho, Sheila; Barros Dias, Ádila Liliane; Lacerda Ulysses de Carvalho, André; Beratarrechea, Andrea Gabriela; et al.; Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth; BioMed Central; Malaria Journal; 21; 1; 12-2022; 1-11 1475-2875 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12936-022-04047-3 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
BioMed Central |
publisher.none.fl_str_mv |
BioMed Central |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269934389821440 |
score |
13.13397 |